EACR Cancer Neuroscience Conference

The nervous system influences cancer in many ways, and vice versa. This bidirectional crosstalk between both the central and peripheral nervous system and cancer has changed our understanding of malignant diseases throughout the body. Recent seminal discoveries in the emerging field of cancer neuroscience have already led to new therapeutic concepts that target harmful neuro-cancer interactions. The first EACR conference on this exciting and rapidly evolving topic brings together international leaders of the field: to identify the most relevant current insights, and to develop a roadmap for future preclinical, translational and clinical research.
14 October 2025
to 16 October 2025
The Euskalduna Conference Centre
, Bilbao

Visit biomodal at booth 

#4

About the event

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.

Presenting at the event

Coming soon, keep checking back for more information

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

Attending from biomodal

Tom Charlesworth

Tom Charlesworth, PhD

Director of Market Strategy and Corporate Development
Rachel Aldridge

Rachel West

Regional Marketing Manager EMEA
Gianina LaChapelle

Gianina LaChapelle

Regional Marketing Manager
Aziz Mustafa

Aziz Mustafa, PhD

Director of Sales and Business Development, Europe

Register now

EACRBilbao25

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal